News for AnGes, Inc. (4563.T)

Published at

May 29, 2024 5:10 AM

by marketscreener.com

positive

positive

AnGes : Tie2 receptor agonist (AV 001), co development product, received fast track designation from the U.S. FDA

May 29, 2024 Company Name: AnGes Inc. Presentative: Ei Yamada, President & CEO Tie2 receptor agonist ,co-development...

AMGXF 4563.T

Read more →
Published at

May 13, 2024 7:00 PM

by globenewswire.com

mixed

mixed

Global Chest Drainage Catheters Market to Exhibit Growth at a CAGR of ~5% by 2030 | DelveInsight

The surge in demand for chest drainage catheters is mainly driven by several factors. These include the rising number of patients with cardiovascular...

UTMD TFX TBH.DE T1FX34.SA LIVN HMTXF HEM.V CAHD.BA 084990.KQ BSX.MX BSX-PA BSX B1SX34.SA AMGXF 4563.T 0HOY.L

Read more →
Published at

Jan 18, 2024 11:50 PM

by marketscreener.com

positive

positive

Eiger and Partner, AnGes, Receive Approval for Zokinvy® (lonafarnib) for Hutchinson- Gilford Progeria Syndrome and Processing-Deficient Progeroid Laminopathies in Japan

Clinical trial data demonstrated Zokinvy treatment extended life by an average of 4.3 years in children and young adults with Hutchinson-Gilford progeriaEiger to receive $500,000 approval milestone...

EIGR AMGXF 4563.T

Read more →
Published at

Jan 18, 2024 11:49 PM

by marketscreener.com

positive

positive

Eiger BioPharmaceuticals, Inc. and Partner, AnGes, Inc. Receive Approval for Zokinvy for Hutchinson- Gilford Progeria Syndrome and Processing-Deficient Progeroid Laminopathies in Japan

Eiger BioPharmaceuticals, Inc. announced that it and its partner AnGes, Inc. received marketing approval from the Ministry of Health, Labour and Welfare for Zokinvy , a treatment for...

EIGR AMGXF 4563.T

Read more →
Published at

Sep 26, 2023 11:01 PM

by prnewswire.com

mixed

mixed

Atherosclerotic Cardiovascular Disease Market to Observe Impressive Growth at a CAGR of 2.2% by 2032, Predicts DelveInsight

/PRNewswire/ -- DelveInsight's Atherosclerotic Cardiovascular Disease Market Insights report includes a comprehensive understanding of current treatment...

RVXCF RVX.TO NVON.MX NVO NOVOBN.MX NOVC.DE NOVA.DE NONOF AMGN.MX AMGN.BA AMGN AMG.DE 0TDD.L SLNCF SLN.L SLN IONS.MX IONS 0JDI.L HUMA BSX.MX BSX-PA BSX B1SX34.SA AMGXF 4563.T 0HOY.L

Read more →
Published at

Aug 24, 2023 11:01 PM

by prnewswire.com

mixed

mixed

Peripheral Artery Disease Global Market to Surpass USD 54 Billion Mark by 2027 | DelveInsight

/PRNewswire/ -- DelveInsight's Peripheral Artery Disease Market Insights report provides the current and forecast market analysis, individual leading...

RYLPF PHIAN.MX PHIA.DE PHIA.AS PHI1.DE PHG.BA PHG TRUMY TRUMF MRKD.BA MRK.SN MRK.PA MRK.MX MRK HMTXF HEM.V CSII 6MK.DE 4543N.MX 4543.T 084990.KQ BSX.MX BSX-PA BSX B1SX34.SA AMGXF 4563.T 0HOY.L

Read more →
Published at

Aug 14, 2023 10:05 PM

by prnewswire.com

mixed

mixed

Eiger BioPharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Business Update

/PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), a commercial-stage biopharmaceutical company focused on the development of innovative therapies...

AMGXF 4563.T EIGR

Read more →
Published at

Aug 2, 2023 11:01 PM

by prnewswire.com

mixed

mixed

Atherosclerosis Market to Witness Growth by 2032, Estimates DelveInsight | Leading Companies - CSL Behring, Novartis, Merck, Amgen, Ionis , BioMarin, AstraZeneca

/PRNewswire/ -- DelveInsight's Atherosclerosis Market Insights report includes a comprehensive understanding of current treatment practices, atherosclerosis...

MRKD.BA MRK.SN MRK.PA MRK.MX MRK IONS.MX IONS AMGN.MX AMGN.BA AMGN AMG.DE 6MK.DE 0JDI.L REGN34.SA REGN.MX REGN PFED.BA PFECL.SN PFE.SN PFE.MX PFE.DE PFE 0R2M.L HUMA BSX.MX BSX-PA BSX B1SX34.SA AMGXF 4563.T 0HOY.L

Read more →
Published at

Jul 24, 2023 5:50 AM

by marketscreener.com

positive

positive

AnGes : Clinical Research Laboratory has now established "Genetic Testing" technology and aims to begin accepting orders for "genetic testing" in winter 2023

July 24, 2023 Company Name: AnGes Inc. Presentative: Ei Yamada, President & CEO AnGes Clinical Research Laboratory has...

AMGXF 4563.T

Read more →
Published at

Jul 18, 2023 8:21 AM

by marketscreener.com

neutral

neutral

AnGes : Begin contracted expanded newborn screening from municipalities and related institutions from April 2024 on AnGes Clinical Research Laboratory

July 18, 2023 Company Name: AnGes Inc. Presentative: Ei Yamada, President & CEO Begin contracted expanded newborn...

AMGXF 4563.T

Read more →
Published at

Oct 29, 2022 8:26 AM

by etfdailynews.com

positive

positive

Brickell Biotech (NASDAQ:BBI) & AVROBIO (NASDAQ:AVRO) Financial Comparison

Read Brickell Biotech (NASDAQ:BBI) & AVROBIO (NASDAQ:AVRO) Financial Comparison at ETF Daily News

BBI AVRO AMGXF 4572.T 4563.T

Read more →
Published at

Sep 27, 2022 12:45 AM

by prnewswire.com

mixed

mixed

Degenerative Disc Disease Market Size to Grow by USD 1.03 billion, Launch of Innovative Products to be a Key Trend - Technavio

/PRNewswire/ -- One of the key trends in the degenerative disc disease market is the launch of innovative products. Technologically advanced products are more...

AMGXF 4563.T ZIM.DE ZBH.MX ZBH PFED.BA PFECL.SN PFE.SN PFE.MX PFE.DE PFE MDTN.MX MDT.BA MDT GMED.MX GMED BRTXQ BRTX BOTHE.BR 2M6.DE 0Y6X.L 0R55.L

Read more →
Published at

Sep 24, 2022 10:16 AM

by etfdailynews.com

positive

positive

Financial Contrast: Palisade Bio (NASDAQ:PALI) and Brickell Biotech (NASDAQ:BBI)

Read Financial Contrast: Palisade Bio (NASDAQ:PALI) and Brickell Biotech (NASDAQ:BBI) at ETF Daily News

PALI BBI AMGXF 4572.T 4563.T

Read more →
Published at

Sep 1, 2022 7:42 AM

by etfdailynews.com

mixed

mixed

Brickell Biotech (NASDAQ:BBI) vs. Aptose Biosciences (NASDAQ:APTO) Financial Review

Read Brickell Biotech (NASDAQ:BBI) vs. Aptose Biosciences (NASDAQ:APTO) Financial Review at ETF Daily News

BBI APTO APS.TO 4572.T AMGXF 4563.T

Read more →
Published at

Aug 16, 2022 7:18 AM

by etfdailynews.com

positive

positive

Financial Comparison: Quantum Genomics Société Anonyme (OTCMKTS:QNNTF) vs. Brickell Biotech (NASDAQ:BBI)

Read Financial Comparison: Quantum Genomics Société Anonyme (OTCMKTS:QNNTF) vs. Brickell Biotech (NASDAQ:BBI) at ETF Daily News

QNNTF BBI AMGXF ALQGC.PA 4572.T 4563.T 0D1J.L

Read more →
Published at

Aug 14, 2022 8:04 AM

by etfdailynews.com

mixed

mixed

Financial Comparison: Brickell Biotech (NASDAQ:BBI) & Fusion Pharmaceuticals (NASDAQ:FUSN)

Read Financial Comparison: Brickell Biotech (NASDAQ:BBI) & Fusion Pharmaceuticals (NASDAQ:FUSN) at ETF Daily News

FUSN BBI 4572.T AMGXF 4563.T

Read more →
Published at

Jun 16, 2022 8:16 PM

by etfdailynews.com

mixed

mixed

Head-To-Head Analysis: Brickell Biotech (NASDAQ:BBI) vs. BioCryst Pharmaceuticals (NASDAQ:BCRX)

Read Head-To-Head Analysis: Brickell Biotech (NASDAQ:BBI) vs. BioCryst Pharmaceuticals (NASDAQ:BCRX) at ETF Daily News

BCRX.MX BCRX BBI AMGXF 4572.T 4563.T SGIOY SGIOF 4551.T 4507.T 006280.KS

Read more →
Published at

May 10, 2022 10:30 PM

by prnewswire.com

positive

positive

Eiger BioPharmaceuticals and AnGes Announce Exclusive Partnership for Regulatory Approval and Commercialization of Zokinvy® (lonafarnib) in Japan

/PRNewswire/ -- Eiger Biopharmaceuticals Inc. ("Eiger", Nasdaq: EIGR) and AnGes Inc. ("AnGes", TYO: 4563) today announced that the companies entered into an...

EIGR AMGXF 6392.T 4563.T

Read more →
Published at

Feb 1, 2022 9:30 PM

by prnewswire.com

mixed

mixed

Global Cell & Gene Therapy Market Research Report 2022: Expanding Application for Cell & Gene Therapies & Growing Demand for CAR T- Cell Therapies

/PRNewswire/ -- The

GILDD.BA BRM.DE BMYB34.SA BMY.MX BMY.BA BMY BLUE.MX BLUE AMGXF 4563.T 0HOH.L 086820.KQ NUVA.MX NUVA KRYS 8086.T

Read more →
Published at

Aug 26, 2021 8:00 PM

by prnewswire.com

mixed

mixed

Asia-Pacific Gene Therapy Markets, 2021-2030 - Product Launches and Grants / Outsourcing of Vector and Gene Therapy Manufacturing

/PRNewswire/ -- The "Asia-Pacific Gene Therapy Market Research Report: Type, Vector Type, Application, End User - Industry Analysis and Demand Forecast to...

AMGN.MX AMGN.BA AMGN AMG.DE NVSN.MX NVSEF NVSD.BA NVS NOVN.SW N1VS34.SA AMGXF 4563.T 102940.KQ 0K9E.L

Read more →